MRK
66
3
LH
48
5
MS
76
2
DVA
51
2
PNR
54
3
ALLE
46
2
VIX
19
-6
PEG
50
4
DLTR
58
-5
TAP
37
8
PRGO
43
4
UA
36
3
ADI
73
2
ITW
40
3
PCAR
56
4
CHRW
79
-3
MNST
59
3
PEP
32
-3
LMT
62
3
PH
64
2
MRK
66
3
LH
48
5
MS
76
2
DVA
51
2
PNR
54
3
ALLE
46
2
VIX
19
-6
PEG
50
4
DLTR
58
-5
TAP
37
8
PRGO
43
4
UA
36
3
ADI
73
2
ITW
40
3
PCAR
56
4
CHRW
79
-3
MNST
59
3
PEP
32
-3
LMT
62
3
PH
64
2
Financhill
Back

Coca-Cola FEMSA SAB de CV Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
60

KOF
Coca-Cola FEMSA SAB de CV

Last Price:
$95.91
Seasonality Move:
3.06%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
60
Coca-Cola FEMSA SAB de CV (KOF) is a Buy

Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?

  • The current Coca-Cola FEMSA SAB de CV [KOF] share price is $94.50. The Score for KOF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • KOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KOF Stock Price Chart

What is Coca-Cola FEMSA SAB de CV's stock price today?

  • The Coca-Cola FEMSA SAB de CV share price today is $94.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

KOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 65.18 Buy
Chaikin Money Flow: 111709 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.65 - 92.89) Buy
Bollinger Bands (100): (83.05 - 89.53) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

KOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.23 Buy
20-day SMA: 90.9 Buy
50-day SMA: 88.3 Buy
200-day SMA: 89.5 Buy
8-day EMA: 93.15 Buy
20-day EMA: 91.51 Buy
50-day EMA: 89.2 Buy
200-day EMA: 87.91 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Coca-Cola FEMSA SAB de CV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):